HomeCancerLung

Lung

Lung

IDEAYA Biosciences Soars on Most cancers Drug Examine Outcomes

Editor -
Key Takeaways IDEAYA Biosciences reported optimistic outcomes from a Part 2 trial of its experimental drug to deal with sure bladder and small-cell lung...
Lung

ADAURA Trial Exhibits How MRD Might Predict Advantage of Adjuvant Remedy in EGFR-Optimistic NSCLC – DocWire Information

Editor -
ADAURA Trial Exhibits How MRD Might Predict Advantage of Adjuvant Remedy in EGFR-Optimistic NSCLC  DocWire Information
Lung

IDEAYA Pronounces Optimistic Interim Section 2 Monotherapy Growth Knowledge for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Most cancers

Editor -
~39% General Response Charge (ORR): 1 CR and 6 PRs (2 awaiting affirmation) by RECIST 1.1 out of 18 evaluable MTAP-deletion urothelial and...
Lung

Completely different clinicopathological options between younger and older sufferers with pulmonary adenocarcinoma and ground-glass opacity

Editor -
Leiter, A. et al. The worldwide burden of lung most cancers: Present standing and future developments. Nat. Rev. Clin. Oncol. 20(9), 624–639 (2023).PubMed  ...
Lung

AstraZeneca’s Tagrisso positive factors EU approval for lung most cancers therapy

Editor -
Betsy Goodfellow | July 8, 2024 | Information story | Medical Communications |  AstraZeneca, Oncology, Tagrisso, lung most cancers  AstraZeneca has introduced that the EU’s...
1...606162...82Page 61 of 82

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.